Showing results (2201-2210 of 8,982) with videos related to
Sort By:
Pageof 899
Journal of Hepatology|May 27, 2021
Sarcopenia and frailty in decompensated cirrhosisPuneeta Tandon, Aldo J Montano-Loza, Jennifer C Lai, et al.Journal of Hepatology|May 27, 2021
The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needsPeter Jepsen, Zobair M YounossiJournal of Hepatology|May 27, 2021
Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunctionCornelius Engelmann, Joan Clària, Gyongyi Szabo, et al.Journal of Hepatology|December 5, 2020
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patientsMireia García-López, Sabela Lens, Laura J Pallett, et al.Journal of Hepatology|November 28, 2020
Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearanceTongxin Wang, Kai Chen, Weilei Yao, et al.Journal of Hepatology|October 10, 2020
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosisCatherine Frenette, Zeid Kayali, Edward Mena, et al.Journal of Hepatology|October 11, 2020
Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasisShi-Ying Cai, Dongke Yu, Carol J Soroka, et al.Journal of Hepatology|August 1, 1987
Highly symptomatic adult polycystic disease of the liver. A report of fifteen casesK J van Erpecum, A R Janssens, J L Terpstra, et al.Journal of Hepatology|August 1, 1987
Copper protects against galactosamine-induced hepatitisL Barrow, A Kantarjian, M S TannerJournal of Hepatology|August 1, 1987
Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatmentL J Scully, R Shein, P Karayiannis, et al.Pageof 899